
KOL Strategic Briefing & Engagement Builder
Synthesize clinical evidence into compliant KOL briefings and multi-touch engagement strategies
What You Can Do
Transform clinical data and competitive intelligence into focused KOL briefing materials that align with each opinion leader's expertise and patient populations. Map influence networks to identify priority engagement touchpoints, design multi-phase engagement campaigns with measurable outcomes, and generate compliant advisory board agendas, speaker briefings, and scientific summaries—all within strict pharma compliance boundaries.
Features
Distill trial data, real-world evidence, and competitive positioning into KOL-relevant, expertise-aligned briefing documents
Identify key opinion leaders, their networks, patient populations, and priority engagement touchpoints across specialties
Plan 12-24 month KOL engagement roadmaps with speaker programs, advisory boards, clinical trial engagement, and thought leadership milestones
Produce advisory board agendas, speaker briefing decks, scientific summaries, and engagement documentation that meet OPPI and regulatory requirements
Build outcome-based tracking dashboards and sentiment assessment tools to measure relationship progress and clinical position shifts
Generate engagement rationale, conflict-of-interest assessments, and compliance-ready audit trails for all KOL interactions
Synthesize clinical gaps, treatment barriers, and emerging therapeutic opportunities relevant to each KOL's practice setting
Example Output
Example 1: KOL Briefing Document
KOL: Dr. Sarah Chen, Oncology — Non-Small Cell Lung Cancer (NSCLC)
Clinical Summary
- Emerging resistance to first-line PD-L1 inhibitors in 35-40% of NSCLC patients; clinical rationale for biomarker-driven sequencing
- [Your Company] Phase 2b data shows 62% ORR in PD-L1 negative, high-mutation subgroup vs. 38% SOC
- Real-world data gap: Limited evidence in patients with EGFR mutations + high tumor mutational burden
Engagement Touchpoints
- Q2 2024: Advisory board (unmet need validation, trial design feedback)
- Q3 2024: Speaker program launch (3 events, 200 oncologist audience)
- Q4 2024: Clinical trial advisory role (patient selection, outcomes monitoring)
Example 2: Influence Network Map
Tier 1 (National/Institutional Leaders)
├─ Dr. Chen (Tier 1, NSCLC, 1,200 annual patient volume)
├─ Dr. Patel (Tier 1, IO/Oncology, 850 annual patient volume)
Tier 2 (Regional/Specialist Leaders)
├─ Dr. Martinez (Tier 2, Academic Center, Research-focused)
└─ Dr. Okonkwo (Tier 2, Community Oncology, Prescriber influence)
Engagement Priority: Dr. Chen → Dr. Patel → Regional Tier 2 leaders → Community prescribers
What's Included
- SKILL.md: Complete system instruction for KOL strategy generation
- KOL Profile Template: Standardized format capturing expertise, patient populations, influence reach, prior engagement history, and compliance flags
- Clinical Briefing Outline: Structure for evidence synthesis, unmet need positioning, competitive landscape, and trial/program alignment
- Advisory Board Planning Checklist: Agenda design, disclosure requirements, outcomes documentation, compliance sign-off
- Multi-Touch Engagement Roadmap Template: 12-24 month campaign timeline with speaker programs, advisory boards, clinical engagement, and decision gates
- OPPI Compliance Documentation Worksheet: Engagement rationale, conflict-of-interest assessment, payment tracking, and audit-ready records
Who It's For
- Medical Affairs Managers — Designing and executing KOL engagement strategies within compliance guardrails
- Clinical Engagement Leads — Building advisory boards and speaker programs with strategic scientific positioning
- Pharma Marketing/Commercial Teams — Aligning KOL relationships with product launch, market share, and thought leadership goals
- Clinical Trial Recruitment Specialists — Engaging opinion leaders for patient enrollment, site recruitment, and outcome monitoring
- Compliance & Regulatory Affairs — Auditing KOL engagement rationale, documentation, and OPPI/payment tracking
Best For
- Pre-meeting KOL briefing document preparation (60-90 minute meetings)
- Advisory board planning, agenda design, and material generation
- Multi-year KOL relationship roadmap and engagement campaign design
- Speaker program recruitment, positioning, and compliance documentation
- KOL network mapping and influence tier prioritization by indication
- Clinical trial advisory engagement and patient population strategy
- OPPI compliance documentation and engagement rationale audit trails







